SlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Oral Abstract Presentation #1 | Promise TaiwoView Slideset
OSOana SăndulescuMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Women’s Health Throughout the Life Cycle | Oana SăndulescuView Slideset
JMLJosep M. LlibreMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Personalized Treatment Regimens | Josep M. LlibreView Slideset
AWAnnemarie WensingMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Andrea De Luca Lecture - Low Level Viremia: Is It Clinically Relevant? | Annemarie WensingView Slideset
DADaniele ArmeniaPhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Charles Boucher Lecture - Resistance Testing in Routine Care: What a Clinician Needs to Know | Daniele ArmeniaView Slideset
LWLaura WatersMD, FRCPSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Weight Gain and ARV Therapy: What a Clinician Needs to Know | Laura WatersView Slideset
DGDeniz GökenginMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Prevention of STIs: The Role of Doxy-PEP | Deniz GökenginView Slideset
AMGAnna Maria GerettiMD, PhD, FRCPathSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024Resistance Considerations in Choosing PrEP Across Europe | Anna Maria GerettiView Slideset
MMMichael MeulbroekSlidesetHIVViral Hepatitis and Liver DiseaseRSVCOVID-19European Meeting on HIV & Hepatitis 2024The Role of Social and Structural Determinants on Access to PrEP | Michael MeulbroekView Slideset
TLThuy LeMD, DPhilSlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2024Innovation in Fungal Diagnostics_Thuy Le_SlidesetView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2024Preferences for accessing pre-exposure prophylaxis among men who have (...) - Warittha Tieosapjaroen_SlidesetView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2024Assessing HIV prevention coverage (...) Results from the PrEP APPEAL Study - Benjamin R BavintonView Slideset
